The Trump administration expanded TrumpRx, a clearinghouse that lets cash-paying patients buy prescription medications without insurance, adding 160 medications to the program.
Roughly 12 million people have used the service and saved about $500 million, according to figures cited by Dr. Mehmet Oz.
A consumer-facing push
The expansion is part of the administration's effort to lower out-of-pocket drug costs by routing buyers directly to discounted cash prices, bypassing the traditional insurance pathway.
Supporters say the approach gives patients transparency and savings; critics question how broadly the benefits reach those with complex or chronic prescription needs.
